Latest filing published 15 Sept 2026 for Zimmer Biomet Holdings, INC., €455k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kevin R. Thornal is a declared insider at 3 companies (chief executive); the most frequent names are Hologic Inc, Nevro Corp and Zimmer Biomet Holdings, Inc. We count 39 filings; the first trade dates from 11 November 2019 and the latest from 11 September 2026.
Every open-market trade on record is a sale: 6 sales worth €3.5M. Besides market trades, the filings include 27 share grants and 5 option exercises. 2026 to date brings no purchases and 1 sale.
Most recently, on 15 September 2026, the filings show an open-market sale worth €455k in Zimmer Biomet Holdings, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations